Myung In Pharmaceutical LTD. (KRX:317450)
South Korea · Delayed Price · Currency is KRW 42,550
-800 (-1.85%)
At close: Oct 8, 2026
KRX:317450 Market Cap
KRX:317450 has a market cap or net worth of 621.23 billion as of October 8, 2026. It is the 15,312th most valuable company in the world and the 421st biggest in South Korea. Its market cap has decreased by 63.26% in one year.
Market Cap
621.23B
Enterprise Value
152.21B
Revenue
293.03B
Global Rank
Country Rank
#421 South Korea
PE Ratio
6.62
ChartMarket Cap Chart
Since October 1, 2025, KRX:317450's market cap has decreased from 1.78T to 621.23B, a decrease of -65.09%. That is a compound annual growth rate of -64.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 621.23B | -38.24% |
| Dec 30, 2025 | 1.01T | -43.48% |
| Oct 1, 2025 | 1.78T | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 59.05T |
| Celltrion | 41.92T |
| ALTEOGEN | 16.90T |
| Samsung Epis Holdings | 8.53T |
| Boryung | 720.96B |
| InBody Co.,Ltd | 688.68B |
| Onconic Therapeutics | 673.40B |
| Hyundai Bioscience | 663.94B |